Skip to main content
Cytotechnology logoLink to Cytotechnology
editorial
. 2000 Nov;34(3):181–183. doi: 10.1023/A:1008160817560

Safety for vaccine(e)s

O-W Merten 1
PMCID: PMC3449631  PMID: 19003393

Full Text

The Full Text of this article is available as a PDF (20.6 KB).

References

  1. Beale AJ. Cell substrate for killed poliovaccine production. Dev Biol Standard. 1981;47:19–23. [PubMed] [Google Scholar]
  2. Brands R, Visser J, Medema J, Palache AM, van Scharrenburg GJM. Influvac TC: A safe madin darby canine kidney (MDCK) cell culture-based influenza vaccine. Dev Biol Standard. 1999;98:93–100. [PubMed] [Google Scholar]
  3. Cinatl J, Jr, Cinatl J, Rabenau H, Rapp J, Kornhuber B, Doerr H-W. Protein-free culture of Vero cells: A substrate for replication of human pathogenic viruses. Cell Biol Int. 1993;17:885–895. doi: 10.1006/cbir.1993.1152. [DOI] [PubMed] [Google Scholar]
  4. Hohenblum H, Naschberger S, Katinger H and Mattanovich D (2000) Production of recombinant human trypsinogen in Escherichia coli and Pichia pastoris-A comparison of expression systems. Presented at the EFB Meeting on Recombinant protein production with prokaryotic and eukaryotic cells. A comparative view on host physiology. Semmering/A, 5.-8.10.2000.
  5. Maurer HR. Towards chemically-defined, serum-free media for mammalian cell culture. In: Freshney RI, editor. Animal Cell Culture. A Practical Approach. Oxford, U.K.: IRL Press; 1986. pp. 13–31. [Google Scholar]
  6. Merten O-W. Cell detachment. In: RE S., editor. Encyclopedia of Cell Technology. New York, U.S.A.: J. Wiley & Sons, Inc.; 1999. pp. 351–365. [Google Scholar]
  7. Merten O-W, Kallel H, Manuguerra J-C, Tardy-Panit M, Crainic R, Delpeyroux F, van der Werf S, Perrin P. The new medium MDSS2N, free of any animal protein supports growth and production of various viruses. Cytotechnology. 1999;30:191–201. doi: 10.1023/A:1008021317639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Merten O-W, Kierulff JV, Castignolles N, Perrin P. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: Use of various cell lines. Cytotechnology. 1994;14:47–59. doi: 10.1007/BF00772195. [DOI] [PubMed] [Google Scholar]
  9. Merten O-W, Wu R, Couvé E, Crainic R. Evaluation of the serum-free medium MDSS2 for the production of poliovirus on Vero cells in bioreactors. Cytotechnology. 1997;25:35–44. doi: 10.1023/A:1007999313566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Meslin F-X. Actualité sur la lutte contre la rage humaine et la vaccination antirabique. Cahiers Santé. 1994;45:203–204. [PubMed] [Google Scholar]
  11. Montagnon BJ, Fanget B, Vincent-Falquet JC. Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier. Rev Infect Dis. 1984;6(S2):210–213. doi: 10.1093/clinids/6.supplement_2.s341. [DOI] [PubMed] [Google Scholar]
  12. Morgeaux S, Tordo N, Gontier C and Perrin P (1993) Beta-propiolactone treatment impairs tile biological activity of residual DNA from BHK-21 cells infected with rabies virus. Vaccine 11, 82-90. New Century Pharmaceuticals, Inc. http://www.newcenturypharm.com. [DOI] [PubMed]
  13. Pay TWF, Boge A, Menard FJRR, Radlett PJ. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process. Dev Biol Standard. 1985;60:171–174. [PubMed] [Google Scholar]
  14. Perrin P, Madhusudana S, Gontier-Jallet C, Petres S, Tordo N, Merten O-W. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: Use of serum-free medium and perfusion-reactor system. Vaccine. 1995;13:1244–1250. doi: 10.1016/0264-410x(94)00022-f. [DOI] [PubMed] [Google Scholar]
  15. Petricciani JC. The liberation of animal cells: Psychology of changing attitudes. In: Spier RE, Griffiths JB, editors. Modern Approaches to Animal Cell Technology. Sevenoaks/U.K.: Butterworths; 1987. pp. 1–19. [Google Scholar]
  16. Petricciani JC. Ongoing tragedy of rabies. Lancet. 1993;342:1067. doi: 10.1016/0140-6736(93)92058-2. [DOI] [PubMed] [Google Scholar]
  17. Radlett PJ, Pay TWF, Garland AJM. The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period. Dev Biol Standard. 1985;60:163–170. [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES